Aimed Bio Inc. 0009K0
KRX · South Korea · Commercial Services
KRW 25,450.00+3,100.00 (+13.87%)
Market closed· · KRW · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · KRW · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
As global markets navigate a complex landscape marked by technology sector volatility and economic resilience, Asia's tech industry continues to capture investor attention with its potential for high growth amidst uneven economic recoveries. In this environment, identifying strong stocks often involves looking for companies that demonstrate robust innovation capabilities and adaptability to shifting market dynamics, particularly in sectors like artificial intelligence where commercialization...
In May 2026, Asian markets are witnessing a robust performance, with the technology sector taking center stage amid a backdrop of resilient domestic demand and optimism around AI-related advancements. As key indices like China's CSI 300 Index and Hong Kong's Hang Seng Index show positive momentum, investors are increasingly focusing on high-growth tech stocks that demonstrate strong fundamentals and adaptability to evolving market conditions.
Recent third-party headlines about this company, kept separate from Makkler's own editorial coverage and linking out to the publisher. Accuracy is the publisher's responsibility.